×
ADVERTISEMENT

benralizumab

FDA Approves Fasenra for Severe Eosinophilic Asthma

The FDA approved benralizumab for the add-on maintenance treatment of patients with severe eosinophilic phenotype ...

NOVEMBER 15, 2017

Load more